Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Greenall SA"'
Autor:
Greenall SA; Department of Oncology, Monash University and Monash Health, Clayton, Victoria, Australia.; Centre for Cancer Research, Hudson Institute of Medical Research, Clayton, Victoria, Australia.; Brain Cancer Discovery Collaborative, New South Wales, Australia., McKenzie M; School of Life and Environmental Sciences, Deakin University, Geelong, Victoria, Australia.; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Victoria, Australia.; Department of Molecular and Translational Science, Monash University, Clayton, Victoria, Australia., Seminova E; CSIRO Manufacturing, Parkville, Victoria, Australia., Dolezal O; CSIRO Manufacturing, Parkville, Victoria, Australia., Pearce L; CSIRO Manufacturing, Parkville, Victoria, Australia., Bentley J; CSIRO Manufacturing, Parkville, Victoria, Australia., Kuchibhotla M; Cancer Centre, Telethon Kids Institute, Nedlands, Western Australia, Australia., Chen SC; Centre for Cancer Research, Hudson Institute of Medical Research, Clayton, Victoria, Australia.; Department of Molecular and Translational Science, Monash University, Clayton, Victoria, Australia., McDonald KL; Brain Cancer Discovery Collaborative, New South Wales, Australia.; Cure Brain Cancer Biomarkers and Translational Research Group, Prince of Wales Clinical School, University of New South Wales, New South Wales, Australia., Kornblum HI; The Intellectual and Developmental Disabilities Research Center, University of California, Los Angeles, California, USA., Endersby R; Brain Cancer Discovery Collaborative, New South Wales, Australia.; Cancer Centre, Telethon Kids Institute, Nedlands, Western Australia, Australia., Adams TE; CSIRO Manufacturing, Parkville, Victoria, Australia., Johns TG; Brain Cancer Discovery Collaborative, New South Wales, Australia.; Cancer Centre, Telethon Kids Institute, Nedlands, Western Australia, Australia.
Publikováno v:
Neuro-oncology [Neuro Oncol] 2019 Aug 05; Vol. 21 (8), pp. 1016-1027.
Autor:
Greenall SA; CSIRO Manufacturing, Parkville, VIC 3052, Australia; Oncogenic Signalling Laboratory and Brain Cancer Discovery Collaborative Centre for Cancer Research, Hudson Institute of Medical Research, Clayton, VIC 3168, Australia; Monash University, Clayton, VIC 3168, Australia. Electronic address: sameer.greenall@hudson.org.au., Donoghue J; Oncogenic Signalling Laboratory and Brain Cancer Discovery Collaborative Centre for Cancer Research, Hudson Institute of Medical Research, Clayton, VIC 3168, Australia; Monash University, Clayton, VIC 3168, Australia. Electronic address: jacqueline.donoghue@hudson.org.au., Johns TG; Oncogenic Signalling Laboratory and Brain Cancer Discovery Collaborative Centre for Cancer Research, Hudson Institute of Medical Research, Clayton, VIC 3168, Australia; Monash University, Clayton, VIC 3168, Australia; Telethon Kids Institute, Subiaco, WA 6008, Australia. Electronic address: terrance.johns@telethonkids.org.au., Adams TE; CSIRO Manufacturing, Parkville, VIC 3052, Australia. Electronic address: Tim.Adams@csiro.au.
Publikováno v:
Translational oncology [Transl Oncol] 2018 Aug; Vol. 11 (4), pp. 971-978. Date of Electronic Publication: 2018 Jun 22.
Autor:
Donoghue JF; Oncogenic Signalling Group, Hudson Institute of Medical Research, 21⁻37 Wright Street, Clayton, VIC 3168, Australia. jacqueline.donoghue@unimelb.edu.au., Kerr LT; Oncogenic Signalling Group, Hudson Institute of Medical Research, 21⁻37 Wright Street, Clayton, VIC 3168, Australia. Lauren.Kerr@cancer.org.uk.; Department of Molecular and Translational Science, Monash University, Clayton, VIC 3168, Australia. Lauren.Kerr@cancer.org.uk., Alexander NW; Telethon Kids Cancer Centre, Telethon Kids Institute, University of Western Australia, Perth, WA 6008, Australia. naomi.alexander@telethonkids.org.au., Greenall SA; Oncogenic Signalling Group, Hudson Institute of Medical Research, 21⁻37 Wright Street, Clayton, VIC 3168, Australia. sameer.greenall@hudson.org.au.; Department of Molecular and Translational Science, Monash University, Clayton, VIC 3168, Australia. sameer.greenall@hudson.org.au., Longano AB; Department of Anatomical Pathology, Monash Medical Centre, Clayton, VIC 3168, Australia. anthony.longano@monashhealth.org., Gottardo NG; Telethon Kids Cancer Centre, Telethon Kids Institute, University of Western Australia, Perth, WA 6008, Australia. Nicholas.Gottardo@telethonkids.org.au., Wang R; Department of Neurosurgery and Center for Stem Cell Biology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. wangr@mskcc.org., Tabar V; Department of Neurosurgery and Center for Stem Cell Biology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. tabarv@mskcc.org., Adams TE; Biomedical Manufacturing, Commonwealth Scientific and Industrial Research Organisation (CSIRO), Parkville, VIC 3052, Australia. Tim.Adams@csiro.au., Mischel PS; Ludwig Institute for Cancer Research, University of California San Diego, La Jolla, CA 92093, USA. pmischel@ucsd.edu., Johns TG; Oncogenic Signalling Group, Hudson Institute of Medical Research, 21⁻37 Wright Street, Clayton, VIC 3168, Australia. Terrance.Johns@telethonkids.org.au.; Department of Molecular and Translational Science, Monash University, Clayton, VIC 3168, Australia. Terrance.Johns@telethonkids.org.au.; Telethon Kids Cancer Centre, Telethon Kids Institute, University of Western Australia, Perth, WA 6008, Australia. Terrance.Johns@telethonkids.org.au.
Publikováno v:
Cancers [Cancers (Basel)] 2018 Jul 25; Vol. 10 (8). Date of Electronic Publication: 2018 Jul 25.
A Pre-Clinical Assessment of the Pan-ERBB Inhibitor Dacomitinib in Pediatric and Adult Brain Tumors.
Autor:
Endersby R; Brain Tumor Research Program, Telethon Kids Cancer Centre, Telethon Kids Institute, University of Western Australia, Perth, Western Australia, Australia., Whitehouse J; Brain Tumor Research Program, Telethon Kids Cancer Centre, Telethon Kids Institute, University of Western Australia, Perth, Western Australia, Australia., Hii H; Brain Tumor Research Program, Telethon Kids Cancer Centre, Telethon Kids Institute, University of Western Australia, Perth, Western Australia, Australia., Greenall SA; Oncogenic Signaling Laboratory, Monash Institute of Medical Research, Clayton, Victoria, Australia., Johns TG; Brain Tumor Research Program, Telethon Kids Cancer Centre, Telethon Kids Institute, University of Western Australia, Perth, Western Australia, Australia; Oncogenic Signaling Laboratory, Monash Institute of Medical Research, Clayton, Victoria, Australia., Gottardo NG; Brain Tumor Research Program, Telethon Kids Cancer Centre, Telethon Kids Institute, University of Western Australia, Perth, Western Australia, Australia; Department of Pediatric Oncology and Hematology, Princess Margaret Hospital for Children, Subiaco, Western Australia, Australia; Division of Paediatrics, School of Medicine, University of Western Australia, Crawley, Western Australia, Australia. Electronic address: nick.gottardo@health.wa.gov.au.
Publikováno v:
Neoplasia (New York, N.Y.) [Neoplasia] 2018 May; Vol. 20 (5), pp. 432-442. Date of Electronic Publication: 2018 Mar 22.
Autor:
Greenall SA; Centre for Cancer Research, Hudson Institute of Medical Research, Clayton, Victoria, Australia.; Brain Cancer Discovery Collaborative, Australia.; Monash University, Clayton, Victoria, Australia., Lim YC; Brain Cancer Discovery Collaborative, Australia.; Translational Brain Cancer Research Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Mitchell CB; Brain Cancer Discovery Collaborative, Australia.; Focal Adhesion Biology Group, Children's Hospital at Westmead, Westmead, New South Wales, Australia., Ensbey KS; Brain Cancer Discovery Collaborative, Australia.; Translational Brain Cancer Research Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Stringer BW; Brain Cancer Discovery Collaborative, Australia.; Translational Brain Cancer Research Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Wilding AL; Centre for Cancer Research, Hudson Institute of Medical Research, Clayton, Victoria, Australia.; Brain Cancer Discovery Collaborative, Australia.; Monash University, Clayton, Victoria, Australia., O'Neill GM; Brain Cancer Discovery Collaborative, Australia.; Focal Adhesion Biology Group, Children's Hospital at Westmead, Westmead, New South Wales, Australia., McDonald KL; Brain Cancer Discovery Collaborative, Australia.; Cure Brain Cancer Neuro-Oncology Laboratory, Prince of Wales Clinical School, University of New South Wales, Sydney, New South Wales, Australia., Gough DJ; Centre for Cancer Research, Hudson Institute of Medical Research, Clayton, Victoria, Australia.; Monash University, Clayton, Victoria, Australia., Day BW; Brain Cancer Discovery Collaborative, Australia.; Translational Brain Cancer Research Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Johns TG; Centre for Cancer Research, Hudson Institute of Medical Research, Clayton, Victoria, Australia.; Brain Cancer Discovery Collaborative, Australia.; Monash University, Clayton, Victoria, Australia.
Publikováno v:
Oncogenesis [Oncogenesis] 2017 May 15; Vol. 6 (5), pp. e336. Date of Electronic Publication: 2017 May 15.
Autor:
Greenall SA; Centre for Cancer Research, Hudson Institute of Medical Research, Clayton, Victoria 3168, Australia; Monash University, Clayton, Victoria 3800, Australia., Johns TG; Centre for Cancer Research, Hudson Institute of Medical Research, Clayton, Victoria 3168, Australia; Monash University, Clayton, Victoria 3800, Australia.
Publikováno v:
Cell death discovery [Cell Death Discov] 2016 Jul 04; Vol. 2, pp. 16049. Date of Electronic Publication: 2016 Jul 04 (Print Publication: 2016).
Autor:
Greenall SA; a Oncogenic Signalling Laboratory and Brain Cancer Discovery Collaborative, Centre for Cancer Research, Hudson Institute of Medical Research , 27-31 Wright Street, Clayton , VIC 3168 , Australia.; b Monash University, Wellington Parade , Clayton , VIC 3800 , Australia.; c Biomedical Manufacturing Program, Commonwealth Scientific and Industrial Research Organisation , 343 Royal Parade, Parkville , VIC 3052 , Australia., Adams TE; c Biomedical Manufacturing Program, Commonwealth Scientific and Industrial Research Organisation , 343 Royal Parade, Parkville , VIC 3052 , Australia., Johns TG; a Oncogenic Signalling Laboratory and Brain Cancer Discovery Collaborative, Centre for Cancer Research, Hudson Institute of Medical Research , 27-31 Wright Street, Clayton , VIC 3168 , Australia.; b Monash University, Wellington Parade , Clayton , VIC 3800 , Australia.
Publikováno v:
MAbs [MAbs] 2016; Vol. 8 (2), pp. 246-52.
Autor:
Greenall SA; Oncogenic Signalling Laboratory and Brain Cancer Discovery Collaborative, Centre for Cancer Research, MIMR-PHI Institute of Medical Research, Clayton, VIC, Australia.; Monash University, Clayton, VIC, Australia.; Division of Materials Science and Engineering, Commonwealth Scientific and Industrial Research Organisation, Parkville, VIC, Australia., Donoghue JF; Oncogenic Signalling Laboratory and Brain Cancer Discovery Collaborative, Centre for Cancer Research, MIMR-PHI Institute of Medical Research, Clayton, VIC, Australia.; Monash University, Clayton, VIC, Australia., Van Sinderen M; Oncogenic Signalling Laboratory and Brain Cancer Discovery Collaborative, Centre for Cancer Research, MIMR-PHI Institute of Medical Research, Clayton, VIC, Australia.; Monash University, Clayton, VIC, Australia., Dubljevic V; Oncogenic Signalling Laboratory and Brain Cancer Discovery Collaborative, Centre for Cancer Research, MIMR-PHI Institute of Medical Research, Clayton, VIC, Australia.; Monash University, Clayton, VIC, Australia., Budiman S; Oncogenic Signalling Laboratory and Brain Cancer Discovery Collaborative, Centre for Cancer Research, MIMR-PHI Institute of Medical Research, Clayton, VIC, Australia.; Monash University, Clayton, VIC, Australia., Devlin M; Peter MacCallum Cancer Centre, St Andrews Place, East Melbourne, VIC, Australia., Street I; CRC for Cancer Therapeutics, Bundoora, VIC, Australia.; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.; Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia., Adams TE; Division of Materials Science and Engineering, Commonwealth Scientific and Industrial Research Organisation, Parkville, VIC, Australia., Johns TG; Oncogenic Signalling Laboratory and Brain Cancer Discovery Collaborative, Centre for Cancer Research, MIMR-PHI Institute of Medical Research, Clayton, VIC, Australia.; Monash University, Clayton, VIC, Australia.
Publikováno v:
Oncogene [Oncogene] 2015 Oct 08; Vol. 34 (41), pp. 5277-87. Date of Electronic Publication: 2015 Feb 09.
Autor:
Greenall SA; 160;CSIRO Division of Materials Science and Engineering, Parkville, VIC, Australia., Donoghue JF; Oncogenic Signaling Laboratory and Brain Cancer Discovery Collaborative, Monash Institute of Medical Research, Clayton, VIC, Australia., Gottardo NG; Telethon Institute for Child Health Research and Brain Cancer Discovery Collaborative, Centre for Child Health Research, Subiaco, WA, Australia., Johns TG; Oncogenic Signaling Laboratory and Brain Cancer Discovery Collaborative, Monash Institute of Medical Research, Clayton, VIC, Australia., Adams TE; 160;CSIRO Division of Materials Science and Engineering, Parkville, VIC, Australia.
Publikováno v:
Oncogene [Oncogene] 2015 Mar 26; Vol. 34 (13), pp. 1658-66. Date of Electronic Publication: 2014 Apr 21.
Effects of gefitinib, an epidermal growth factor receptor inhibitor, on human placental cell growth.
Autor:
Nilsson UW; Translational Obstetrics Group, University of Melbourne, Mercy Hospital for Women, Heidelberg, the Ritchie Centre and the Centre for Cancer Research, Monash Institute of Medical Research, Monash University, and the Embryo Implantation Group, Prince Henry's Institute of Medical Research, Clayton, Victoria, Australia; Department of Anatomy and Developmental Biology, Monash University, Clayton, Victoria, Australia; the 2 Affiliated Hospital, Xian Jiatong University School of Medicine, Xian Jiatong, China; and the MRC Centre for Reproductive Health, The Queen's Medical Research Institute, Edinburgh, United Kingdom., Johns TG, Wilmann T, Kaitu'u-Lino T, Whitehead C, Dimitriadis E, Menkhorst E, Saglam B, Gao Y, Greenall SA, Horne AW, Tong S
Publikováno v:
Obstetrics and gynecology [Obstet Gynecol] 2013 Oct; Vol. 122 (4), pp. 737-744.